Steven D. Rubin
Executive Vice President- AdministrationatOpko Health· In proxies 2021–2025
Pay in FY2025-15% from the year before · Opko Health stock -14.3% the same year
Steven D. Rubin was paid $1.6M in FY2025 (Dec), down 15%. Opko Health stock fell 14.3% that year.
Pay$100 in the stock at the end of FY20 → $32
Experience
- Opko HealthPublic company · 5 yr
- Executive Vice President- Administration2021 – Present · 5 yrStock in role -62%
- ChromaDex Corp.Public company
- Director? – PresentNo stock prices for these years
- Cocrystal Pharma, Inc.Public company
- Director? – PresentNo stock prices for these years
- Eloxx Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Entera Bio LtdPublic company
- Director? – PresentNo stock prices for these years
- Niagen Bioscience, Inc.Public company
- Director? – PresentNo stock prices for these years
- Red Violet, Inc.Public company
- Director? – PresentNo stock prices for these years
- Castle Brands, Inc.Public company
- Director? – PresentNo stock prices for these years
- Cogint, Inc.Public company
- Director? – PresentNo stock prices for these years
- Fluent, Inc.Public company
- Director? – PresentNo stock prices for these years
- Kidville, Inc.Public company
- Director? – PresentNo stock prices for these years
- Neovasc, Inc.Public company
- Director? – PresentNo stock prices for these years
- Non-Invasive Monitoring Systems, Inc.Public company
- Director? – PresentNo stock prices for these years
- VBI Vaccines, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Boards1
- Opko HealthDirector · 18 yr on the boardNot independent—Paid as an executive
Board seats come from each company's latest proxy statement.
Activity
Two people shown as one, or a wrong number?